Concepedia

Publication | Closed Access

HDAC inhibitors synergize antiproliferative effect of sorafenib in renal cell carcinoma cells.

30

Citations

13

References

2012

Year

Mi Joung Kim, Dong‐Eun Kim, In Gab Jeong, Jene Choi, Se-Jin Jang, Je‐Hwan Lee, Seonggu Ro, Jung Jin Hwang, Choung‐Soo Kim
PubMed

Abstract

Sorafenib is more effective in combination with HDACIs even for clear cell RCCs harboring mutant VHL.

References

YearCitations

Page 1